Amalgamated Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7M Sell
226,028
-12,847
-5% -$1.04M 0.12% 114
2026
Q1
$20.7M Buy
238,875
+1,654
+0.7% +$158K 0.16% 101
2025
Q4
$22.8M Sell
237,221
-10,677
-4% -$1.04M 0.16% 93
2025
Q3
$23.6M Sell
247,898
-4,362
-2% -$401K 0.17% 91
2025
Q2
$22M Buy
252,260
+308
+0.1% +$26.1K 0.17% 96
2025
Q1
$22.6M Buy
251,952
+2,844
+1% +$254K 0.19% 89
2024
Q4
$19.9M Sell
249,108
-4,281
-2% -$371K 0.16% 94
2024
Q3
$22.8M Sell
253,389
-15,067
-6% -$1.27M 0.19% 89
2024
Q2
$21.1M Sell
268,456
-7,213
-3% -$591K 0.18% 88
2024
Q1
$24M Sell
275,669
-47,236
-15% -$4.03M 0.21% 80
2023
Q4
$26.6M Sell
322,905
-15,535
-5% -$1.18M 0.21% 79
2023
Q3
$26.5M Sell
338,440
-4,807
-1% -$402K 0.23% 73
2023
Q2
$30.2M Sell
343,247
-5,474
-2% -$471K 0.24% 69
2023
Q1
$28.1M Buy
348,721
+12
+0% +$978 0.24% 76
2022
Q4
$27.1M Buy
348,709
+2,357
+0.7% +$191K 0.24% 77
2022
Q3
$28M Buy
346,352
+7,033
+2% +$632K 0.27% 61
2022
Q2
$30.5M Buy
339,319
+657
+0.2% +$66.6K 0.28% 60
2022
Q1
$37.6M Buy
+338,662
New +$35.8M 0.29% 56
2020
Q4
Sell
-76,254
Closed -$7.92M 1594
2020
Q3
$7.92M Buy
+76,254
New +$7.66M 0.34% 49
2020
Q2
Sell
-196,649
Closed -$17.7M 1581
2020
Q1
$17.7M Sell
196,649
-7,488
-4% -$797K 0.43% 43
2019
Q4
$23.2M Buy
204,137
+15,176
+8% +$1.67M 0.43% 40
2019
Q3
$20.5M Sell
188,961
-3,936
-2% -$411K 0.43% 37
2019
Q2
$18.8M Buy
192,897
+20,292
+12% +$1.85M 0.44% 37
2019
Q1
$15.7M Buy
172,605
+5,641
+3% +$505K 0.38% 53
2018
Q4
$15.2M Sell
166,964
-3,222
-2% -$301K 0.43% 41
2018
Q3
$16.7M Sell
170,186
-4,127
-2% -$382K 0.41% 47
2018
Q2
$14.9M Buy
174,313
+3,256
+2% +$272K 0.36% 55
2018
Q1
$13.7M Sell
171,057
-515
-0.3% -$42.5K 0.36% 53
2017
Q4
$13.9M Buy
171,572
+13,803
+9% +$1.11M 0.37% 46
2017
Q3
$12.3M Buy
157,769
+2,871
+2% +$238K 0.38% 48
2017
Q2
$13.7M Buy
154,898
+56,721
+58% +$4.78M 0.45% 38
2017
Q1
$7.91M Buy
98,177
+5,700
+6% +$445K 0.39% 41
2016
Q4
$6.59M Buy
92,477
+26,587
+40% +$2.09M 0.3% 63
2016
Q3
$5.69M Buy
65,890
+7
+0% +$610 0.33% 58
2016
Q2
$5.79M Buy
65,883
+15,032
+30% +$1.22M 0.33% 59
2016
Q1
$3.81M Buy
50,851
+13,535
+36% +$1.02M 0.37% 44
2015
Q4
$2.87M Sell
37,316
-12,204
-25% -$919K 0.35% 45
2015
Q3
$3.31M Buy
49,520
+1,331
+3% +$98K 0.35% 46
2015
Q2
$3.57M Buy
48,189
+2,685
+6% +$205K 0.35% 41
2015
Q1
$3.55M Buy
45,504
+21,824
+92% +$1.65M 0.43% 43
2014
Q4
$1.71M Sell
23,680
-3,815
-14% -$265K 0.27% 68
2014
Q3
$1.7M Buy
27,495
+43
+0.2% +$2.73K 0.25% 75
2014
Q2
$1.75M Buy
27,452
+2,766
+11% +$168K 0.26% 69
2014
Q1
$1.52M Sell
24,686
-463
-2% -$27K 0.26% 67
2013
Q4
$1.44M Sell
25,149
-272
-1% -$15.4K 0.25% 74
2013
Q3
$1.35M Sell
25,421
-601
-2% -$32.3K 0.44% 69
2013
Q2
$1.34M Buy
+26,022
New +$1.29M 0.49% 60

Other funds holding MDT

Amalgamated Bank's MDT Position: Q2 2026 in Review

Amalgamated Bank reduced its Medtronic (MDT) stake by 5.4% in Q2 2026, selling an estimated $1.04M and leaving 226,028 shares worth $17.7M. The position accounts for 0.12% of the portfolio, ranked #114.

Amalgamated Bank first reported a position in MDT in Q2 2013 and has held it in 47 quarters since. The position peaked at $37.6M in Q1 2022. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Amalgamated Bank held 226,028 shares of Medtronic worth $17.7M as of Q2 2026.
  • Amalgamated Bank sold 12,847 Medtronic shares in Q2 2026, an estimated $1.04M.
  • Medtronic made up 0.12% of Amalgamated Bank's portfolio in Q2 2026, its #114 holding.
  • Amalgamated Bank first reported a position in Medtronic in Q2 2013 and has held it in 47 quarters since.
  • Amalgamated Bank's Medtronic position peaked at $37.6M in Q1 2022.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.